Tyra Biosciences (TYRA) Cash from Operations (2020 - 2026)
Tyra Biosciences (TYRA) posted Cash from Operations of 32571000.0 for Q1 2026, down 37.87% on a QoQ basis from 23624000.0 in Q4 2025, and down 27.94% year-over-year from 45199919.22 in Q1 2025.
Tyra Biosciences (TYRA) Cash from Operations (2020 - 2026) Analysis & Trends
Tyra Biosciences' Cash from Operations history runs 7 years deep, the most recent figure standing at 32571000.0 for Q1 2026.
- Quarterly Cash from Operations fell 27.94% year-over-year to 32571000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 102255000.0 (down 39.68% YoY) and the FY2025 annual result came in at 95142000.0, down 36.36% from the prior year.
- Cash from Operations was 32571000.0 for Q1 2026 at Tyra Biosciences, down from 23624000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 8925000.0 in Q1 2022 and bottomed at 32571000.0 in Q1 2026.
- A 5-year average of 17524176.47 and a median of 17168000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 284.85% — and 2023, when it surged 43.99%.
- Tyra Biosciences' Cash from Operations stood at 11980000.0 in 2022, then slipped by 12.95% to 13532000.0 in 2023, then sank by 44.77% to 19590000.0 in 2024, then declined by 20.59% to 23624000.0 in 2025, then slumped by 37.87% to 32571000.0 in 2026.
- Business Quant data shows TYRA's Cash from Operations at 32571000.0 in Q1 2026, 23624000.0 in Q4 2025, and 22380000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - | -32.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.57 Mn |
| Mar 31, 2026 | -32.57 Mn |
| Dec 31, 2025 | -23.62 Mn |
| Dec 31, 2025 | -23.62 Mn |
| Sep 30, 2025 | -22.38 Mn |
| Sep 30, 2025 | -22.38 Mn |
| Jun 30, 2025 | -23.68 Mn |
| Jun 30, 2025 | -23.68 Mn |
| Mar 31, 2025 | -25.46 Mn |
| Mar 31, 2025 | -25.46 Mn |
| Dec 31, 2024 | -19.59 Mn |
| Dec 31, 2024 | -19.59 Mn |
| Sep 30, 2024 | -17.90 Mn |
| Sep 30, 2024 | -17.90 Mn |
| Jun 30, 2024 | -10.26 Mn |
| Jun 30, 2024 | -10.26 Mn |
| Mar 31, 2024 | -22.03 Mn |
| Mar 31, 2024 | -22.03 Mn |
| Dec 31, 2023 | -13.53 Mn |
| Dec 31, 2023 | -13.53 Mn |